The Week in Marijuana News


Bill Introduced in Congress to Exempt Legal Marijuana from Federal Gun Ban – The Daily Chronic

Did you know that it’s illegal for medical marijuana patients to purchase or own firearms? Well, it’s true and it’s all because of a 2011 ruling from The Bureau of Alcohol, Tobacco and Firearms. The Daily Chronic reports “In a memo released at the time, federal firearms dealers were notified that medical marijuana patients are ‘addicts’ or ‘unlawful drug users’ who cannot legally own weapons or ammunition.” Read the rest of the article from The Daily Chronic to find out what steps are being taken to fix this issue.

Read the rest of the article here.

Most Americans Don’t Think Employees Should Be Fired For Off-the-Job Pot Use –

How’s that for a headline? Times are certainly changing, and according to a new polls published by the Huffington Post in conjunction with YouGov, a whopping two-thirds of Americans say it’s time for it to be ‘unacceptable’ for employees to be fired for consuming marijuana after work hours. We heartily agree.

Read the rest of the article from here.

Can Smoking Pot Be Considered a Form of Free Speech? –

A man in Philadelphia is arguing that his possession of marijuana was protected under the First Amendment. We’re sure he’s hoping his argument holds water, because if not he could face “six months in prison and $1,000 in fines” according to Apparently this case could be a huge deal if it turns out to be a success. As reports most cases such as this have argued the right to religious freedom to defend their use of marijuana.

Read the entire article here.

Pharmaceutical Company Gets FDA Approval For Marijuana Plant Derived Drug – The Weed Blog

The FDA has granted “orphan drug designation” to GW Pharmaceuticals for their new medication “Epidiolex”. The medication, which will be used to treat children with Dravet syndrome will contain Cannabidiol as the active ingredient. In case you were wondering what exactly ” Orphan drug designation” means the Weed Blog explains it as such:

 “The FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition – generally a disease or condition that affects fewer than 200,000 individuals in the U.S. The first NDA applicant to receive FDA approval for a particular active ingredient to treat a particular disease with FDA orphan drug designation is entitled to a seven-year exclusive marketing period in the U.S. for that product, for that indication.”

The Weed Blog asks some interesting questions about this development. Such as can a major pharmaceutical company produce better medical marijuana products? And if this could be the start of a corporate take over of the medical marijuana industry. What do you think?

Read the entire article here.


One Bunch of Fresh Cannabis Leaves – The New Yorker

You know real change is coming to the world when The New Yorker publishes an article with cannabis recipes. While we have not personally tried out this recipe for “Underground Pop-Up Weed-Dinner Green Congee” it sounds absolutely delightful!

Check out the recipe and the whole article here:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s